Rider, U.S. Olympic Dressage Team Disqualified

Today the Fédération Equestre Internationale (FEI) Tribunal has issued its decision in the positive medication case involving the horse Mythilus ridden by Courtney King-Dye, and representing the U.S. Dressage Team at the 2008 Olympic Games in Hong Kong. The horse was sampled at the Olympic Games on Aug. 19, 2008, and tested positive for felbinac.  

Felbinac is a non-steroidal anti-inflammatory drug used to reduce inflammation and pain. It is classified as "Medication A" Prohibited Substances under the FEI Equine Prohibited List.

The hearing in this case was held at the FEI Headquarters Sept. 7. King-Dye presented testimonies and legal arguments before and during the hearing. The United States Equestrian Federation (USEF) requested that, in case of a decision against King-Dye, the U.S. Dressage Team not be required to forfeit its 4th place at the Olympic Games.

The Tribunal was satisfied that the laboratory reports relating to both the A-Sample and the B-sample reflected that the analytical tests were accurately performed in an acceptable method and that the findings of the laboratory were accurate. The FEI Tribunal was also satisfied that the test results evidenced the presence of felbinac.

The Tribunal did not accept King-Dye's argument that the exception contained in Equine Anti Doping and Medication Control Rules Article 2.1.3 to a medication rule violation in case of an environmental contamination should apply, since felbinac did not appear on the Equine Prohibited List as a threshold substance and no specific criteria was established for it on such List as a contaminant.

The Tribunal repeated its stand that the FEI policy in regard to doping and medication does not only intend to ensure a level playing field but has the additional policy consideration of ensuring that the welfare of the horse is maintained and that horses compete only when they are physically fit and capable of competing. This requires doping and medication rule violations to be strict liability or no fault offenses. King-Dye's arguments that she had gained no competitive advantage and that the findings did not constitute any maltreatment of the horse, due to the nature of the substance and the minimal concentration detected, were therefore not judged to be relevant.

The Tribunal accepted the FEI's position that, under the clear language of EADMCR Article 10.5, in order for King-Dye to prove that she bears no fault and no negligence and that the sanctions should be eliminated, she must demonstrate how the substance entered the horse's systems. While elaborate, the explanations provided were only speculations.

As a result of the foregoing, the horse and King-Dye were disqualified from the Games and all medals, points, and prize money won at the Olympic Games by them are forfeited. Such disqualification is automatic and is not considered a sanction; rather it is an automatic mechanism used to ensure a level playing field.

As a result, the U.S. Dressage Team with its remaining two competitors is also disqualified and loses its 4th place. The Tribunal did not accept the arguments of the USEF that the resulting disqualification of its team, when the sampling was carried days after the end of the team competition, is a "sanction" which is inappropriate in this case and should not be imposed. The Tribunal noted that the resulting disqualification was automatic.

In regard to sanctions, the Tribunal considered the fact that the King-Dye is an experienced sportswoman and that the behavior of anyone at the top of the sport and particularly at the Olympic Games must be faultless since the eyes of the world focus on performances at such events.

On the other hand, the Tribunal found the evidence of King-Dye and the U.S. Dressage Team Vet to be credible, and believed that neither King-Dye nor anyone on her behalf or related to the USEF had knowingly administered the medication to the horse. The Tribunal further accepted King-Dye's and the USEF's arguments that they have done almost everything in their power to ensure that no rule violations occurred.

The Tribunal also considered other factors, including:

  • The type of Medication A substance involved and its therapeutic applications;
  • The fact that the same substance may not be considered as a doping substance;
  • The specific circumstances relating to the horse's hospitalization in Hong Kong and the possibility of contamination;
  • The excellent stable management practiced by the U.S. team and measures placed to try and ensure that no horse with prohibited substances participates at the Olympic Games;
  • The efforts made by King-Dye and the USEF to determine the source of the positive finding; and
  • King-Dye's impeccable record and reputation, and her cooperation in the investigation, as well as the hardship already caused to her by the team's disqualification.

As a consequence, the Tribunal imposed a one month suspension on King-Dye, which commenced on the date of the provisional suspension and ended Sept. 21, along with a fine and costs.

Stay on top of the most recent Horse Health news with FREE weekly newsletters from TheHorse.com. Learn More